Kane Biotech Successfully Completes Safety and Biocompatibility Studies for DispersinB® Wound Gel in Preparation for Human Clinical Trials
DispersinB® wound gel accelerates wound healing WINNIPEG, Manitoba, March 22, 2022 (GLOBE NEWSWIRE) — Kane…
DispersinB® wound gel accelerates wound healing WINNIPEG, Manitoba, March 22, 2022 (GLOBE NEWSWIRE) — Kane…
Ji’an, Jiangxi, China, March 22, 2022 (GLOBE NEWSWIRE) — Universe Pharmaceuticals INC (the “Company”) (Nasdaq:…
BOSTON and JERUSALEM, March 22, 2022 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), a…
Arcutis Skin Insights: Uncovering Psoriasis Survey Arcutis Skin Insights: Uncovering Psoriasis Survey Arcutis Skin Insights:…
Conference Call and Live Audio Webcast Scheduled for Wednesday, March 30, 2022, 8:00 a.m. ET…
Dosing in the first cohort discontinued after multiple reports of ALT flares suggestive of drug-induced…
FORT COLLINS, Colo., March 22, 2022 (GLOBE NEWSWIRE) — Statera Biopharma, Inc. (NASDAQ: STAB) (the…
Cauley to Lead Development of Company’s Proprietary DNA Data Storage Technology SAN DIEGO, March 22,…
LAVAL, Québec, March 22, 2022 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”)…
BOSTON, March 22, 2022 (GLOBE NEWSWIRE) — Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company…
Results support the feasibility for development of a potential treatment for critically ill patients with…
Tempol Reduced Lung Inflammation After High Dose Challenge SAN DIEGO, March 22, 2022 (GLOBE NEWSWIRE)…
ZÜRICH, Switzerland, March 22, 2022 (GLOBE NEWSWIRE) — CDR-Life Inc., a biotechnology company pioneering a…
Renowned neuroscientist brings pioneering drug development expertise and vision to emerging leader in next-generation AAV…
BEDMINSTER, N.J., March 22, 2022 (GLOBE NEWSWIRE) — Matinas BioPharma (NYSE AMER: MTNB), a clinical-stage…
BOCA RATON, Fla., March 22, 2022 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc., (NASDAQ: FWBI),…
BERKELEY HEIGHTS, N.J., March 22, 2022 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ:…
Customized vaccine selectively targets toxic amyloid-beta oligomers TORONTO, Ontario and CAMBRIDGE, Mass., March 22, 2022…
DEVON, Pa., March 22, 2022 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader…
What you need to know: Empowering online instructors to create an effective learning environment, BlueJeans…